Cargando…
SARS-CoV-2 Variants, Vaccines, and Host Immunity
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new beta coronavirus that emerged at the end of 2019 in the Hubei province of China. SARS-CoV-2 causes coronavirus disease 2019 (COVID-19) and was declared a pandemic by the World Health Organization (WHO) on 11 March 2020. Herd or co...
Autores principales: | Mistry, Priyal, Barmania, Fatima, Mellet, Juanita, Peta, Kimberly, Strydom, Adéle, Viljoen, Ignatius M., James, William, Gordon, Siamon, Pepper, Michael S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761766/ https://www.ncbi.nlm.nih.gov/pubmed/35046961 http://dx.doi.org/10.3389/fimmu.2021.809244 |
Ejemplares similares
-
Open access and its potential impact on public health – A South African perspective
por: Strydom, Adéle, et al.
Publicado: (2022) -
Coronavirus Host Genetics South Africa (COHG-SA) database—a variant database for gene regions associated with SARS-CoV-2 outcomes
por: Barmania, Fatima, et al.
Publicado: (2022) -
Consequences of HIV infection in the bone marrow niche
por: Herd, Candice Lee, et al.
Publicado: (2023) -
A COVID-19 Vaccine: Big Strides Come with Big Challenges
por: Mellet, Juanita, et al.
Publicado: (2021) -
C-C chemokine receptor type five (CCR5): An emerging target for the control of HIV infection()
por: Barmania, Fatima, et al.
Publicado: (2013)